BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37776708)

  • 21. Selective Elimination of NRF2-Activated Cells by Competition With Neighboring Cells in the Esophageal Epithelium.
    Hirose W; Horiuchi M; Li D; Motoike IN; Zhang L; Nishi H; Taniyama Y; Kamei T; Suzuki M; Kinoshita K; Katsuoka F; Taguchi K; Yamamoto M
    Cell Mol Gastroenterol Hepatol; 2023; 15(1):153-178. PubMed ID: 36115578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2.
    Han M; Li N; Li F; Wang H; Ma L
    Hum Cell; 2020 Jul; 33(3):641-651. PubMed ID: 32419118
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Akdemir B; Nakajima Y; Inazawa J; Inoue J
    Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Jiang X; Zhou X; Yu X; Chen X; Hu X; Lu J; Zhao H; Cao Q; Gu Y; Yang Y; Jiang W; Jin M
    Mod Pathol; 2022 Jul; 35(7):929-937. PubMed ID: 35194221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspase-8 mutants activate Nrf2 via phosphorylating SQSTM1 to protect against oxidative stress in esophageal squamous cell carcinoma.
    Li L; Feng R; Li Y; Yu X; Liu Y; Zhao Y; Liu Z
    Free Radic Biol Med; 2022 Nov; 192():51-62. PubMed ID: 36165926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.
    Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J
    Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
    Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
    Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma.
    Arora M; Kumari S; Kadian L; Anupa G; Singh J; Kumar A; Verma D; Pramanik R; Kumar S; Yadav R; Chopra A; Chauhan SS
    Biosci Rep; 2023 Sep; 43(9):. PubMed ID: 37531267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 30. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
    Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
    J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
    Zhu ZQ; Hu HF; Zheng XY; Wang F
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpressed COL3A1 has prognostic value in human esophageal squamous cell carcinoma and promotes the aggressiveness of esophageal squamous cell carcinoma by activating the NF-κB pathway.
    Zhou J; Yang Y; Zhang H; Luan S; Xiao X; Li X; Fang P; Shang Q; Chen L; Zeng X; Yuan Y
    Biochem Biophys Res Commun; 2022 Jul; 613():193-200. PubMed ID: 35598375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma.
    Mizumoto A; Ohashi S; Kamada M; Saito T; Nakai Y; Baba K; Hirohashi K; Mitani Y; Kikuchi O; Matsubara J; Yamada A; Takahashi T; Lee H; Okuno Y; Kanai M; Muto M
    J Gastroenterol; 2019 Aug; 54(8):687-698. PubMed ID: 30737573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
    Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
    Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
    Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
    [No Abstract]   [Full Text] [Related]  

  • 40. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
    BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.